British researchers are developing a testosterone hormone patch to help combat symptoms linked to menopause, which if successful would be a world first that could help women secure better access to a ...

Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. A new testosterone patch to alleviate ...

Q: I was looking forward to getting the much-talked-about testosterone patch, so I’m disappointed it wasn’t approved. What are my alternatives? A: The testosterone patch was a focus of many women’s ...

Although testosterone is the primary male hormone, women also need it. After menopause, however, they produce much less, which can lessen their sex drives. Although women have access to patches to ...

Researchers in the UK are developing the world’s only testosterone patch aimed at easing symptoms experienced as a result of the menopause. Low levels of testosterone following the menopause can cause ...

(HealthDay News) – Evidence suggests that transdermal testosterone patches may relieve symptoms of hypoactive sexual desire disorder (HSDD) in postmenopausal women, according to a review published ...

Think of it as patching up the libido. A company-sponsored test of Procter & Gamble's Intrinsa testosterone patches for women published on Wednesday found that a high dose of the male hormone gives ...

A testosterone patch for women with menopausal symptoms is being developed by researchers who say it could have a "huge" impact on loss of sex drive. Medherant, a company founded by the University of ...

Hypogonadal men found to have greater clinical improvement with transdermal delivery. TORONTO—Smooth and prolonged release of testosterone by transdermal delivery (Testopatch) translates into greater ...

Transdermal exogenous testosterone improves libido in postmenopausal women receiving estrogen therapy. Davis et al. have now demonstrated that 300 µg of testosterone a day, administered via skin ...

Since Viagra burst onto the market in 1998, men experiencing sexual dysfunction have had a tool to treat it. But the same cannot be said for women -- until now. The American College of Obstetrics and ...

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ treatment, and many physicians are reluctant to ...